In the need for redefining the function of c-MYC in liver fibrogenesis, cirrhosis and end-stage HCC, it is necessary to explore pathways regulated by c-MYC and, ultimately, link these data with clinical outcomes and therapeutic strategies. Here, MYC is linked to hepatocellular carcinoma.